Proteomic profiling of human liver biopsies: Hepatitis C virus–induced fibrosis and mitochondrial dysfunction

Liver biopsies from hepatitis C virus (HCV)‐infected patients offer the unique opportunity to study human liver biology and disease in vivo. However, the low protein yields associated with these small samples present a significant challenge for proteomic analysis. In this study we describe the application of an ultrasensitive proteomics platform for performing robust quantitative proteomic studies on microgram amounts of HCV‐infected human liver tissue from 15 patients at different stages of fibrosis. A high‐quality liver protein database containing 5,920 unique protein identifications supported high throughput quantitative studies using 16O/18O stable isotope labeling in combination with the accurate mass and time (AMT) tag approach. A total of 1,641 liver biopsy proteins were quantified, and analysis of variance (ANOVA) identified 210 proteins exhibiting statistically significant differences associated with fibrosis stage. Hierarchical clustering showed that biopsies representative of later fibrosis stages (for example, Batts‐Ludwig stages 3–4) exhibited a distinct protein expression profile, indicating an apparent down‐regulation of many proteins when compared with samples from earlier fibrosis stages (for example, Batts‐Ludwig stages 0–2). Functional analysis of these signature proteins suggests that impairment of key mitochondrial processes including fatty acid oxidation and oxidative phosphorylation, and response to oxidative stress and reactive oxygen species occurs during advanced stage 3 to 4 fibrosis. Conclusion: The results reported here represent a significant advancement in clinical proteomics providing to our knowledge, the first demonstration of global proteomic alterations accompanying liver disease progression in patients chronically infected with HCV. Our findings contribute to a generally emerging theme associating oxidative stress and hepatic mitochondrial dysfunction with HCV pathogenesis. (HEPATOLOGY 2007.)

[1]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[2]  F. McLafferty,et al.  High-resolution electrospray mass spectra of large molecules , 1991 .

[3]  Richard E. Sampliner,et al.  The Natural History of Community-Acquired Hepatitis C in the United States , 1993 .

[4]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[5]  Elizabeth S. Pietras,et al.  Chronic Hepatitis: An Update on Terminology and Reporting , 1996 .

[6]  X. Yao,et al.  Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus. , 2001, Analytical chemistry.

[7]  A. Siddiqui,et al.  Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Sook Y. Lee,et al.  Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites. , 2001, Virology.

[9]  T. Veenstra,et al.  Packed capillary reversed-phase liquid chromatography with high-performance electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for proteomics. , 2001, Analytical chemistry.

[10]  Eugene R. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[11]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[12]  Ljiljana Paša-Tolić,et al.  ESI-FTICR mass spectrometry employing Data-dependent external ion selection and accumulation , 2002, Journal of the American Society for Mass Spectrometry.

[13]  Michael G. Katze,et al.  Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.

[14]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[15]  Mark P Molloy,et al.  Overcoming technical variation and biological variation in quantitative proteomics , 2003, Proteomics.

[16]  Gordon A Anderson,et al.  Use of artificial neural networks for the accurate prediction of peptide liquid chromatography elution times in proteome analyses. , 2003, Analytical chemistry.

[17]  Yan-Hwa Wu Lee,et al.  Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-β/Smad3-mediated transcriptional activation , 2004, Oncogene.

[18]  V. Thorsson,et al.  Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells*S , 2004, Molecular & Cellular Proteomics.

[19]  A. Lonardo,et al.  Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. , 2004, Gastroenterology.

[20]  Richard D. Smith,et al.  Ultra-sensitive, high throughput and quantitative proteomics measurements , 2005 .

[21]  Ronald J Moore,et al.  Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach*S , 2005, Molecular & Cellular Proteomics.

[22]  Michael G. Katze,et al.  Proteome Analysis of Liver Cells Expressing a Full-Length Hepatitis C Virus (HCV) Replicon and Biopsy Specimens of Posttransplantation Liver from HCV-Infected Patients , 2005, Journal of Virology.

[23]  J. Auwerx,et al.  Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. , 2005, Gastroenterology.

[24]  Kelvin H Lee,et al.  A comparison of the consistency of proteome quantitation using two‐dimensional electrophoresis and shotgun isobaric tagging in Escherichia coli cells , 2005, Electrophoresis.

[25]  Matthew E Monroe,et al.  Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: the human proteome. , 2005, Journal of proteome research.

[26]  J. Ou,et al.  Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[27]  Richard D. Smith,et al.  Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications* , 2006, Molecular & Cellular Proteomics.

[28]  Haojie Lu,et al.  Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon , 2006, Proteomics.

[29]  William M. Lee,et al.  Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Katze,et al.  HepatoProteomics: Applying proteomic technologies to the study of liver function and disease , 2006, Hepatology.

[31]  Michelle S. Scott,et al.  Global Survey of Organ and Organelle Protein Expression in Mouse: Combined Proteomic and Transcriptomic Profiling , 2006, Cell.

[32]  S. Hanash,et al.  Modification of Host Lipid Raft Proteome upon Hepatitis C Virus Replication*S , 2006, Molecular & Cellular Proteomics.

[33]  A. Scaloni,et al.  Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation , 2006, Proteomics.

[34]  S. Weinman,et al.  Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C , 2006, Journal of gastroenterology and hepatology.

[35]  Xiaohui S. Xie,et al.  A Mammalian Organelle Map by Protein Correlation Profiling , 2006, Cell.

[36]  F. Negro.  Mechanisms and significance of liver steatosis in hepatitis C virus infection. , 2006, World journal of gastroenterology.

[37]  Wei Sun,et al.  Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis , 2006, Proteomics.